All Stories

  1. Immunogenic insights and experimental validation of a multiepitope vaccine construct against Streptococcus pneumoniae
  2. Biochemical and Immunological Insights into Capsular Polysaccharide of Streptococcus pneumoniae Serotype 38 (American Type 71)─An Emerging Nonvaccine Serotype
  3. The interplay of tuberculosis and COVID-19: Insights into global health challenges
  4. Promoter characterization of relZ‐bifunctional (pp)pGpp synthetase in mycobacteria
  5. Novel edible multi-epitope vaccine construct against Enterococcus faecalis
  6. Tale of Twin Bifunctional Second Messenger (p)ppGpp Synthetases and Their Function in Mycobacteria
  7. An Unusual Presentation of Superior Mesenteric Venous Occlusion in Mild COVID-19
  8. Vitamin C and its therapeutic potential in the management of COVID19
  9. An Unusual Presentation of Superior Mesenteric Venous Occlusion in Mild COVID-19
  10. Possibility of Relapse of COVID19 in Asymptomatic Cases and Risk Assessment
  11. The extended (p)ppGpp family: New dimensions in Stress response
  12. Guidelines on newly identified limitations of diagnostic tools for COVID‐19 and consequences
  13. COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy
  14. 4-Hydroxy-2-pyridone Derivatives and the δ-pyrone Isostere as Novel Agents Against Mycobacterium smegmatis Biofilm Inhibitors
  15. The role of ω-subunit of Escherichia coli RNA polymerase in stress response
  16. Synthetic Arabinomannan Heptasaccharide Glycolipids Inhibit Biofilm Growth and Augment Isoniazid Effects in Mycobacterium smegmatis
  17. Novel Method for Quantitative Estimation of Biofilms
  18. Synthetic (p)ppGpp Analogue Is an Inhibitor of Stringent Response in Mycobacteria
  19. Vitamin C targets (p)ppGpp synthesis leading to stalling of long-term survival and biofilm formation in Mycobacterium smegmatis
  20. Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure
  21. BCG vaccine fails to prevent the reactivation of latent tuberculosis
  22. Differential binding of ppGpp and pppGpp toE. coliRNA polymerase: photo-labeling and mass spectral studies
  23. Novel pppGpp binding site at the C-terminal region of the Rel enzyme fromMycobacterium smegmatis
  24. Modifications in Trypsin Digestion Protocol for Increasing the Efficiency and Coverage
  25. Combined inhalation and oral supplementation of Vitamin A and Vitamin D: A possible prevention and therapy for tuberculosis
  26. Synthetic Glycolipids and (p)ppGpp Analogs: Development of Inhibitors for Mycobacterial Growth, Biofilm and Stringent Response
  27. Point of care testing for measurement of white blood cell count and C-reactive protein levels in blood
  28. Comments on “Serum Urea:Albumin Ratio as a Prognostic Marker in Critical Patients With Non-chronic Kidney Disease”
  29. VDR, RXR, Coronin-1 and Interferonγ Levels in PBMCs of Type-2 Diabetes Patients: Molecular Link between Diabetes and Tuberculosis
  30. Low plasma levels of cholecalciferol and 13-cis-retinoic acid in tuberculosis: Implications in host-based chemotherapy
  31. Creatinine Estimation and Interference
  32. Streptomycin interference in Jaffe reaction — Possible false positive creatinine estimation in excessive dose exposure
  33. Synthesis of β-arabinofuranoside glycolipids, studies of their binding to surfactant protein-A and effect on sliding motilities of M. smegmatis